Cargando…
The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD
BACKGROUND: The C9ORF72 expansion is one of the most common genetic etiologies observed with behavioural variant frontotemporal dementia (bvFTD). Revised diagnostic criteria for bvFTD (FTDC) were recently introduced but only a few studies have evaluated the accuracy of these criteria. OBJECTIVE: The...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493025/ https://www.ncbi.nlm.nih.gov/pubmed/26146826 http://dx.doi.org/10.1371/journal.pone.0131817 |
_version_ | 1782379848015020032 |
---|---|
author | Solje, Eino Aaltokallio, Heidi Koivumaa-Honkanen, Heli Suhonen, Noora M. Moilanen, Virpi Kiviharju, Anna Traynor, Bryan Tienari, Pentti J. Hartikainen, Päivi Remes, Anne M. |
author_facet | Solje, Eino Aaltokallio, Heidi Koivumaa-Honkanen, Heli Suhonen, Noora M. Moilanen, Virpi Kiviharju, Anna Traynor, Bryan Tienari, Pentti J. Hartikainen, Päivi Remes, Anne M. |
author_sort | Solje, Eino |
collection | PubMed |
description | BACKGROUND: The C9ORF72 expansion is one of the most common genetic etiologies observed with behavioural variant frontotemporal dementia (bvFTD). Revised diagnostic criteria for bvFTD (FTDC) were recently introduced but only a few studies have evaluated the accuracy of these criteria. OBJECTIVE: The objective of the study was to evaluate the applicability of the FTDC criteria and assess the psychiatric history of these patients. METHODS: The study examined 36 patients carrying the C9ORF72 expansion and suffering from bvFTD (N = 32) or from bvFTD with motor neuron disease (bvFTD-MND, N = 4). Neuropsychological, neuropsychiatric, structural brain imaging and PET/SPECT data were evaluated. RESULTS: We found 0.75 sensitivity (SD 0.44, 95%CI 0.57–0.87) for possible bvFTD and 0.64 (SD 0.44, 95%CI 0.57–0.87) for probable bvFTD. The sensitivity was even higher in bvFTD patients without MND, i.e., 0.81 for possible bvFTD and 0.69 for probable bvFTD. PET/SPECT was normal in 17.6% of scanned patients with bvFTD. A history of psychiatric symptoms (psychotic and/or mood symptoms) was detected in 61% of cases. CONCLUSIONS: The FTDC possible and probable bvFTD criteria seem to identify the majority of the C9ORF72 expansion carriers with bvFTD, even though they exhibit only a limited number of behavioral criteria but a significant amount of psychiatric symptoms. The presence of a normal PET/SPECT does not exclude the possibility the C9ORF72 associated bvFTD. |
format | Online Article Text |
id | pubmed-4493025 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-44930252015-07-15 The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD Solje, Eino Aaltokallio, Heidi Koivumaa-Honkanen, Heli Suhonen, Noora M. Moilanen, Virpi Kiviharju, Anna Traynor, Bryan Tienari, Pentti J. Hartikainen, Päivi Remes, Anne M. PLoS One Research Article BACKGROUND: The C9ORF72 expansion is one of the most common genetic etiologies observed with behavioural variant frontotemporal dementia (bvFTD). Revised diagnostic criteria for bvFTD (FTDC) were recently introduced but only a few studies have evaluated the accuracy of these criteria. OBJECTIVE: The objective of the study was to evaluate the applicability of the FTDC criteria and assess the psychiatric history of these patients. METHODS: The study examined 36 patients carrying the C9ORF72 expansion and suffering from bvFTD (N = 32) or from bvFTD with motor neuron disease (bvFTD-MND, N = 4). Neuropsychological, neuropsychiatric, structural brain imaging and PET/SPECT data were evaluated. RESULTS: We found 0.75 sensitivity (SD 0.44, 95%CI 0.57–0.87) for possible bvFTD and 0.64 (SD 0.44, 95%CI 0.57–0.87) for probable bvFTD. The sensitivity was even higher in bvFTD patients without MND, i.e., 0.81 for possible bvFTD and 0.69 for probable bvFTD. PET/SPECT was normal in 17.6% of scanned patients with bvFTD. A history of psychiatric symptoms (psychotic and/or mood symptoms) was detected in 61% of cases. CONCLUSIONS: The FTDC possible and probable bvFTD criteria seem to identify the majority of the C9ORF72 expansion carriers with bvFTD, even though they exhibit only a limited number of behavioral criteria but a significant amount of psychiatric symptoms. The presence of a normal PET/SPECT does not exclude the possibility the C9ORF72 associated bvFTD. Public Library of Science 2015-07-06 /pmc/articles/PMC4493025/ /pubmed/26146826 http://dx.doi.org/10.1371/journal.pone.0131817 Text en © 2015 Solje et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Solje, Eino Aaltokallio, Heidi Koivumaa-Honkanen, Heli Suhonen, Noora M. Moilanen, Virpi Kiviharju, Anna Traynor, Bryan Tienari, Pentti J. Hartikainen, Päivi Remes, Anne M. The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD |
title | The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD |
title_full | The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD |
title_fullStr | The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD |
title_full_unstemmed | The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD |
title_short | The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD |
title_sort | phenotype of the c9orf72 expansion carriers according to revised criteria for bvftd |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493025/ https://www.ncbi.nlm.nih.gov/pubmed/26146826 http://dx.doi.org/10.1371/journal.pone.0131817 |
work_keys_str_mv | AT soljeeino thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT aaltokallioheidi thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT koivumaahonkanenheli thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT suhonennooram thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT moilanenvirpi thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT kiviharjuanna thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT traynorbryan thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT tienaripenttij thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT hartikainenpaivi thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT remesannem thephenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT soljeeino phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT aaltokallioheidi phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT koivumaahonkanenheli phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT suhonennooram phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT moilanenvirpi phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT kiviharjuanna phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT traynorbryan phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT tienaripenttij phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT hartikainenpaivi phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd AT remesannem phenotypeofthec9orf72expansioncarriersaccordingtorevisedcriteriaforbvftd |